PMID- 20565840 OWN - NLM STAT- MEDLINE DCOM- 20101028 LR - 20221207 IS - 1756-9966 (Electronic) IS - 0392-9078 (Print) IS - 0392-9078 (Linking) VI - 29 IP - 1 DP - 2010 Jun 18 TI - Alterations of dendritic cell subsets in the peripheral circulation of patients with cervical carcinoma. PG - 78 LID - 10.1186/1756-9966-29-78 [doi] AB - Patients with cervical carcinoma (CC) are frequently immunocompromised. Dendritic cells (DCs) are potent antigen-presenting cells. Using multicolor flow cytometry, the percentages of CD11c+ (DC1) and CD123+ (DC2) subsets, were determined in the peripheral blood of 37 patients with cervical carcinoma (CC), 54 patients with CIN, and 62 healthy individuals. A substantial reduction of circulating dendritic cells and accordingly immunodepression may be associated with increased IL-6 and TGF-beta in serum. These findings could give expression to the immunosuppression of circulating dendritic cells in patients with CC and CIN, thus, may indicate novel aspects of cervical carcinoma immune evasion. FAU - Ye, Feng AU - Ye F AD - Women's Reproductive Health Key Laboratory of Zhejiang Province, Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Xueshi Rd#2, Hangzhou, 310006, China. FAU - Yu, Yan AU - Yu Y FAU - Hu, Yuting AU - Hu Y FAU - Lu, Weiguo AU - Lu W FAU - Xie, Xing AU - Xie X LA - eng PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20100618 PL - England TA - J Exp Clin Cancer Res JT - Journal of experimental & clinical cancer research : CR JID - 8308647 RN - 0 (Cytokines) SB - IM MH - Case-Control Studies MH - Cytokines/*blood MH - Dendritic Cells/immunology/*pathology MH - Enzyme-Linked Immunosorbent Assay MH - Female MH - Flow Cytometry MH - Humans MH - Prognosis MH - Uterine Cervical Neoplasms/*blood/immunology/pathology MH - Uterine Cervical Dysplasia/*blood/immunology/pathology PMC - PMC2904720 EDAT- 2010/06/23 06:00 MHDA- 2010/10/29 06:00 PMCR- 2010/06/18 CRDT- 2010/06/23 06:00 PHST- 2010/03/29 00:00 [received] PHST- 2010/06/18 00:00 [accepted] PHST- 2010/06/23 06:00 [entrez] PHST- 2010/06/23 06:00 [pubmed] PHST- 2010/10/29 06:00 [medline] PHST- 2010/06/18 00:00 [pmc-release] AID - 1756-9966-29-78 [pii] AID - 10.1186/1756-9966-29-78 [doi] PST - epublish SO - J Exp Clin Cancer Res. 2010 Jun 18;29(1):78. doi: 10.1186/1756-9966-29-78.